Studies of tirzepatide (Zepbound and Mounjaro) have found similar patterns
Against this backdrop, Hims & Hers disclosed during its first-quarter earnings that revenue grew 4% year-over-year to $608.1 million a far cry from the 69% revenue growth it reported in 2024
Comprender la perspectiva a largo plazo es esencial para una toma de decisiones informada
Accessed 03/13/2018
doi: 10.3389/fmed.2025.1594702 Received 16 March 2025 Accepted 27 August 2025 Published 10 September 2025 Volume 12 - 2025 Edited by Etienne Marbaix, Universit Catholique de Louvain, Belgium Reviewed by Andrei Adrian Tica, University of Medicine and Pharmacy of Craiova, Romania Ramiro Cabrera Carranco, Instituto Doyenne, Mexico Updates Copyright 2025 Gao and Du
Pediatric Patients Ages 6 to 17 Years: Maintenance Treatment in ADHD Maintenance of Efficacy Study (Study 6) A double-blind, placebo-controlled, randomized withdrawal study was conducted in pediatric patients ages 6 to 17 years (N=276) who met the diagnosis of ADHD (DSM-IV criteria)
